- Research
- Open access
- Published:
Coronary slow flow research: a bibliometric analysis
European Journal of Medical Research volume 28, Article number: 398 (2023)
Abstract
Background
Studies on coronary slow flow are receiving increasing attention, but objective evaluations are still lacking. The purpose of this study was to visualize the current status and research hotspots of coronary slow flow through bibliometric analysis.
Methods
All relevant publications on coronary slow flow from 2003 to 2022 were extracted from the Web of Science Core Collection database and analyzed by VOSviewer and CiteSpace visualization software. Year of publication, journal, country/region, institution, and first author of each paper, as well as research hotspots were identified.
Results
A total of 913 publications were retrieved. The journal with the most publications was Coronary Artery Disease. The country/region with the most publications was Turkey, followed by China and the United States. The institution with the largest publication volume was Turkey Specialized Higher Education Research Hospital. The author with the largest publication volume was Chun-Yan Ma from China. Keyword analysis indicated that “treatment and prognosis”, “pathogenesis and risk factors” and “diagnosis” were the clustering centers of coronary slow flow, and the research hotspots gradually changed with time, from pathogenesis to treatment and prognosis.
Conclusion
Future research will focus on the search for effective and non-invasive detection indicators and treatments of coronary slow flow. Collaboration needs to be enhanced between different institutions or countries/regions, which would improve clinical outcomes for patients with coronary slow flow.
Background
Coronary slow flow (CSF) was first proposed by Tambe et al. [1] in 1972, and its diagnosis was based on the results of coronary angiography. CSF is characterized by normal or near-normal epicardial coronary arteries (stenosis < 40%) with delayed distal vessel contrast opacification, as evidenced by either thrombolysis in myocardial infarction (TIMI) 2 flow or a corrected TIMI frame count > 27 frames (30 frames/s) in at least one epicardial vessel [2]. CSF can easily go unnoticed for a long time. Angina pectoris is the most common clinical presentation of CSF patients, which affects their quality of life and even leads to ventricular tachyarrhythmias or cardiac death [3,4,5]. Etiology and pathogenesis of CSF are not clearly defined, and there is no effective treatment. Many publications on CSF have been reported, but objective evaluation of the publications and comprehensive summary of research hotspots are still lacking.
Bibliometric analysis is a literature-mining method based on mathematics and statistics that can predict the research status and hotspots within specific domains through information visualization [6, 7]. Based on the Web of Science Core Collection (WoSCC) database, this paper attempts to explore the characteristics and development of publications on CSF from 2003 to 2022 with VOSviewer and CiteSpace visualization software to lay a foundation for future studies.
Methods
Data collection
We searched the WoSCC database from January 2003 to December 2022. The search strategy used to retrieve the data was TS = (coronary slow flow OR slow coronary flow). Only English articles of categories “Article” and “Review” were considered in this study.
Data analysis
Bibliometric analysis was used to analyze the year of publication, journal, country/region, institution, and first author of each paper, as well as research hotspots of publications on CSF. The full records and cited references were exported from the WoSCC database in plain text format. VOSviewer software (version 1.6.18) was used to perform keyword co-occurrence analysis and generate visual maps. CiteSpace software (version 6.2. R2) was used to perform keyword burst analysis and explore the changing trend of publications on CSF.
Results
Annual distribution
A total of 913 publications on CSF were retrieved from the WoSCC database, including 835 primary articles and 78 reviews (Table 1). The publication volume exhibited a fluctuating increase from 2003 to 2015, decreased in 2016 and 2017, and increased rapidly from 2018 to 2022. The total citations increased year by year from 2003 to 2016, decreased in 2017, and increased rapidly from 2018 to 2022 (Fig. 1).
Distribution of journals
The retrieved publications on CSF were published in 340 different journals, the top 15 of which by publication volume are listed in Table 2. The journals with the largest publication volume were Coronary Artery Disease, from the United States (n = 27), and the International Journal of Cardiology, from Ireland (n = 26). The journal with the highest impact factor (IF) was the Journal of the American College of Cardiology (IF = 24, 2022), which had the most total citations (1210).
Distribution of countries/regions
The retrieved publications on CSF were distributed among 56 countries/regions, the top 15 of which by publication number are listed in Table 3. The country/region with the largest publication volume was Turkey (n = 219), followed by China (n = 179) and the United States (n = 167).
VOSviewer software was used to generate a visual map of countries/regions. Figure 2 shows the co-operation networks and relationships between different countries/regions, presented by different-colored nodes and lines. Identically colored nodes indicate countries/regions with a higher frequency of co-occurrence and closer co-operative relationships, putting them in the same cluster. The node size is proportional to the publication volume. The thickness of the line indicates the strength of the co-operative relationship. Forty countries/regions had 3 or more publications, of which the USA had the highest total link strength (total link strength = 113), followed by Italy (total link strength = 55).
Distribution of institutions
The retrieved publications on CSF were distributed among 1379 institutions, the top 15 of which by publication volume are listed in Table 4. The institution with the largest publication volume was Turkey Specialized Higher Education Research Hospital (n = 22), followed by Capital Medical University (n = 21).
VOSviewer software was used to generate a visual map of institutions. Figure 3 shows the co-operation networks and relationships between different institutions presented by different-colored nodes and lines. Identically colored nodes indicate institutions with close co-operative relationships belonging to the same cluster. The node size is proportional to the publication volume. The thicker the line, the stronger the co-operative relationship between different institutions. A total of 145 institutions had 3 or more publications, of which Columbia University had the highest total link strength (publication volume = 9, total link strength = 25), followed by the Cardiovascular Research Foundation (publication volume = 9, total link strength = 23).
Distribution of authors
The retrieved publications on CSF included 4892 authors, the top 15 of whom by publication number are listed in Table 5. The author with the largest publication volume was Chun-Yan Ma from China (n = 14), followed by Mustafa Cetin from Turkey (n = 13) and Yong-Huai Wang from China (n = 12).
VOSviewer software was used to generate a visual map of the authors. Figure 4 shows the co-operation networks and relationships between different authors represented by different-colored nodes and lines. Identically colored nodes indicate authors with close co-operative relationships belonging to the same cluster. The node size is proportional to the publication volume. The thicker the line, the stronger the co-operative relationship between different authors. A total of 227 authors had 3 or more publications, of whom Kenichi Sakakura and Hiroshi Wada from Japan had the highest total link strength (total link strength = 70).
Research hotspots and frontiers
Keyword co-occurrence analysis
We conducted keyword co-occurrence analysis to reveal the research hotspots on CSF via VOSviewer software. The small clusters of keywords that appeared fewer than 10 times were filtered out, and a keyword co-occurrence map of CSF high-frequency keywords containing 3 main clusters was generated.
In Fig. 5, nodes represent keywords, and identically colored nodes belong to the same cluster. The keywords in the same cluster fall under similar research directions. Cluster 1 (red) is summarized as “treatment and prognosis”, which covers 67 keywords, including percutaneous coronary intervention (PCI), acute myocardial infarction, no-reflow phenomenon, angioplasty, intravascular ultrasound, mortality, reperfusion, outcomes, therapy, intervention, etc. Cluster 2 (green) is summarized as “pathogenesis and risk factors”, which covers 49 keywords, including slow coronary flow, atherosclerosis, artery disease, coronary slow flow, inflammation, risk, endothelial function, frame count, C-reactive protein, nitric oxide, etc. Cluster 3 (blue) is summarized as “diagnosis”, which covers 48 keywords, including blood flow, TIMI frame count, dysfunction, ischemia, coronary flow reserve, heart, coronary artery disease, angina, echocardiography, coronary angiography, etc.
Keyword burst analysis
We conducted keyword burst analysis to reveal the changing trend of publications and research frontiers on CSF via CiteSpace software. The 15 keywords with the strongest citation bursts are shown in Fig. 6. The blue line represents the timeline from 2003 to 2022, while the red line represents the length of each burst. Before 2015, studies focused on the pathogenesis of CSF, which was primarily associated with endothelial function and coronary flow reserve. The keywords in this period included nitric oxide, endothelial function, reserve, etc. After 2015, studies focused on disease-related research. Among them, studies focused on ST-elevation myocardial infarction and rotational atherectomy from 2015 to 2017, while studies focused on the treatment and prognosis of CSF from 2018 to 2022. The keywords in this period included ST-elevation myocardial infarction, coronary artery, rotational atherectomy, microvascular obstruction, mortality, outcome, management, association, and impact.
Discussion
It has been more than 50 years since the first detection of CSF [1]. As coronary arteries are not significantly stenotic during coronary angiography in patients with CSF, CSF has not attracted enough attention for a considerable time. However, CSF patients may develop recurrent symptoms of angina pectoris, and even life-threatening cardiovascular events can occur in severe cases, so studies on CSF are receiving increasing attention [5]. To the best of our knowledge, this study is the first bibliometric analysis of CSF. It reflects the current status and research hotspots of CSF in an objective and comprehensive way, which we hope will promote further studies in this field.
This study found that the author with the most publications was Chun-Yan Ma from China. The studies of her team have mainly concentrated on the novel echocardiography-based technique to assess CSF and gene polymorphisms in the pathogenesis of CSF [8, 9]. Six of the top 15 authors by publications on CSF were from Turkey, and some authors had very close co-operative relationships. Among them, Mustafa Cetin, Alpay Turan Sezgin, and Irfan Barutcu ranked in the top 5 authors by publication number. Their research has a wide scope, covering pathogenesis, risk factors, cardiac electrophysiology, ultrasound assessment, treatment, etc. [10,11,12]. We listed the top 15 countries/regions and institutions by publication volume, while the co-operative relationships between different countries/regions and institutions were visualized as visual maps. International co-operation between countries/regions, institutions, and authors should be further enhanced in the field of CSF. This study also compiled quantitative information about journals, which would be helpful in tracking research dynamics and selecting target journals.
The research direction of cluster 1 in the keyword co-occurrence analysis was associated with the treatment and prognosis of CSF. Our keyword burst analysis revealed that the treatment and prognosis of CSF was the main research frontier in recent years, with keywords, such as mortality, outcome, and management. Most studies have focused on pharmacotherapy of CSF, but there is still no safe and effective drug supported by evidence-based medicine. A growing number of studies have found that statin therapy can improve coronary blood flow and coronary flow reserve [5, 13]. Niu et al. [14] performed a prospective randomized trial of 108 patients with CSF and found that atorvastatin could treat CSF by improving endothelial function. Some studies found that dipyridamole and nicorandil could improve left ventricular systolic and diastolic function in patients with CSF [15, 16]. Several other treatments, such as traditional Chinese medicine, hyperbaric oxygen therapy, and cardiac rehabilitation, remain in the exploratory stage [17,18,19].
The high-frequency keywords in cluster 1 included PCI, acute myocardial infarction, and no-reflow phenomenon. Slow flow/no-reflow phenomenon after PCI in myocardial infarction was one main focus of research on CSF. Shah et al. [20] found that predictors built on the basis of history and angiographical features could predict the occurrence of slow flow/no-reflow phenomenon after primary PCI. Reddy et al. [21] found that higher necrotic core volume detected by intravascular ultrasound and virtual histology might be a potential risk factor for CSF phenomenon after PCI in patients with ST-elevation myocardial infarction. Carrick et al. [22] found that deferred stenting might reduce the slow flow/no-reflow phenomenon in primary PCI and increase myocardial salvage.
Cluster 2 in our keyword co-occurrence analysis was associated with the pathogenesis and risk factors for CSF, including keywords, such as atherosclerosis, inflammation and endothelial function. The keywords in the keyword burst analysis were nitric oxide and endothelial function from 2003 to 2014. Earlier studies on the pathogenesis of CSF focused on endothelial dysfunction [23]. A variety of factors can cause endothelial dysfunction, most importantly the imbalance between the production of vasodilatory factors, such as nitric oxide and vasoconstrictive factors such as endothelin [24]. Some studies found that reduced plasma nitric oxide and elevated plasma endothelin-1 were prevalent in patients with CSF [25, 26]. In recent years, an increasing number of studies have found a potential role for factors, such as atherosclerosis, inflammation, gene polymorphisms, and genetic predisposition in the pathogenesis of CSF [27, 28]. Tapar et al. [29] found that CSF could be considered a subgroup of coronary artery diseases with increased intimal thickness in coronary arteries and extensive calcification. Some studies found that inflammatory markers, such as C-reactive protein and the neutrophil-to-lymphocyte ratio, in patients with CSF were significantly elevated compared with patients with normal coronary flow [30, 31]. An in-depth study on the pathogenesis of CSF could provide better evidence for individualized prevention and treatment.
The diagnostic methods of CSF have not received enough attention in previous studies. The diagnosis of CSF is based on coronary angiography. Since coronary angiography is invasive and expensive, the diagnosis and follow-up of CSF are difficult. A series of explorations have been performed to find non-invasive diagnostic markers of CSF [32, 33]. These markers are relatively limited due to their inadequate specificity. Research on novel echocardiography-based techniques for the diagnosis and evaluation of CSF has become a research hotspot in recent years [34, 35], while the application of other imaging methods in the clinical and scientific research fields of CSF is rarely reported. Thus, non-invasive diagnosis of CSF is recommended for future in-depth studies.
There are some limitations to this study. First, only the publications in the WoSCC database were searched, which may have caused some biases in the results. Second, with the rapid updating of publications in the field of CSF, our literature search may have missed some research hotspots.
Conclusions
The study of CSF is of great clinical value. This bibliometric analysis of the literature on CSF reflects the research status and hotspots over the last two decades, visualized with dedicated software. The Journal Coronary Artery Disease, country/region Turkey, and author Chun-Yan Ma were top ranked. Collaboration needs to be enhanced between different countries/regions and institutions, which would improve clinical outcomes for patients with CSF. “Treatment and prognosis”, “pathogenesis and risk factors”, and “diagnosis” were the clustering centers of CSF in the keyword co-occurrence analysis. The research focus gradually moved from pathogenesis to disease-related research to treatment and prognosis over the years. The search for effective and non-invasive detection indicators and treatments of CSF will be the future trends in research. This study will help researchers find relevant literature and academic partners, offer a direction for journal submissions, and provide a reference for the identification of hotspots in the field of CSF.
Availability of data and materials
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Abbreviations
- CSF:
-
Coronary slow flow
- TIMI:
-
Thrombolysis in myocardial infarction
- WoSCC:
-
Web of Science Core Collection
- IF:
-
Impact factor
- PCI:
-
Percutaneous coronary intervention
References
Tambe AA, Demany MA, Zimmerman HA, Mascarenhas E. Angina pectoris and slow flow velocity of dye in coronary arteries–a new angiographic finding. Am Heart J. 1972;84:66–71.
Beltrame JF. Defining the coronary slow flow phenomenon. Circ J. 2012;76:818–20.
Aparicio A, Cuevas J, Morís C, Martín M. Slow coronary blood flow: pathogenesis and clinical implications. Eur Cardiol. 2022;17: e08.
Aksoy S, Öz D, Öz M, Agirbasli M. Predictors of long-term mortality in patients with stable angina pectoris and coronary slow flow. Medicina. 2023;59:763.
Chalikias G, Tziakas D. Slow coronary flow: pathophysiology, clinical implications, and therapeutic management. Angiology. 2021;72:808–18.
Agarwal A, Durairajanayagam D, Tatagari S, Esteves SC, Harlev A, Henkel R, et al. Bibliometrics: tracking research impact by selecting the appropriate metrics. Asian J Androl. 2016;18:296–309.
Gaede J, Rowlands IH. Visualizing social acceptance research: a bibliometric review of the social acceptance literature for energy technology and fuels. Energy Res Soc Sci. 2018;40:142–58.
Zhao C, Zong Z, Zhu Q, Wang Y, Li X, Zhang C, et al. The lncRNA MALAT1 participates in regulating coronary slow flow endothelial dysfunction through the miR-181b-5p-MEF2A-ET -1 axis. Vascul Pharmacol. 2021;138: 106841.
Li J, Wang Y, Zhao C, Zhu Q, Li G, Yang J, et al. Incremental value of three-dimensional echocardiography for evaluating left atrial function in patients with coronary slow flow phenomenon: a case control study. Cardiovasc Ultrasound. 2020;18:6.
Suner A, Cetin M. The effect of trimetazidine on ventricular repolarization indexes and left ventricular diastolic function in patients with coronary slow flow. Coron Artery Dis. 2016;27:398–404.
Barutcu I, Sezgin AT, Sezgin N, Gullu H, Esen AM, Topal E, et al. Increased high sensitive CRP level and its significance in pathogenesis of slow coronary flow. Angiology. 2007;58:401–7.
Gulel O, Akcay M, Soylu K, Aksan G, Yuksel S, Zengin H, et al. Left ventricular myocardial deformation parameters are affected by coronary slow flow phenomenon: a study of speckle tracking echocardiography. Echocardiography. 2016;33:714–23.
Caliskan M, Erdogan D, Gullu H, Topcu S, Ciftci O, Yildirir A, et al. Effects of atorvastatin on coronary flow reserve in patients with slow coronary flow. Clin Cardiol. 2007;30:475–9.
Niu H, Wei Z, Zhang Y, He J, Jia D. Atorvastatin improves coronary flow and endothelial function in patients with coronary slow flow. Exp Ther Med. 2018;15:904–8.
Suner A, Cetin M. Is dipyridamole useful in improving left ventricular systolic and diastolic function in patients with coronary slow flow? Echocardiography. 2016;33:1472–8.
Chen Z, Chen X, Li S, Huo X, Fu X, Dong X. Nicorandil improves myocardial function by regulating plasma nitric oxide and endothelin-1 in coronary slow flow. Coron Artery Dis. 2015;26:114–20.
Wang SH, Chu L, Xu Z, Zhou HL, Chen JF, Ning HF. Effect of Shexiang Tongxin dropping pills on the immediate blood flow of patients with coronary slow flow. Chin J Integr Med. 2019;25:360–5.
Li Y, Zhang H, Liang Y, Wang W, Xu T, Zhang J, et al. Effects of hyperbaric oxygen on vascular endothelial function in patients with slow coronary flow. Cardiol J. 2018;25:106–12.
He W, Huang Y, Zhang Y, She W, Fang L, Wang Z. Cardiac rehabilitation therapy for coronary slow flow phenomenon. Herz. 2020;45:468–74.
Shah GA, Malik T, Farooqi S, Ahmed S, Abid K. Frequency and impact of slow flow / no flow in primary percutaneous coronary intervention. J Pak Med Assoc. 2021;71:2548–53.
Reddy S, Rao KR, Kashyap JR, Kadiyala V, Reddy H, Malhotra S, et al. Impact of plaque burden and composition on coronary slow flow in ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: intravascular ultrasound and virtual histology analysis. Acta Cardiol. 2021;76:650–60.
Carrick D, Oldroyd KG, McEntegart M, Haig C, Petrie MC, Eteiba H, et al. A randomized trial of deferred stenting versus immediate stenting to prevent no- or slow-reflow in acute ST-segment elevation myocardial infarction (DEFER-STEMI). J Am Coll Cardiol. 2014;63:2088–98.
Sezgin AT, Sigirci A, Barutcu I, Topal E, Sezgin N, Ozdemir R, et al. Vascular endothelial function in patients with slow coronary flow. Coron Artery Dis. 2003;14:155–61.
Godo S, Shimokawa H. Endothelial functions. Arterioscler Thromb Vasc Biol. 2017;37:e108–14.
Camsarl A, Pekdemir H, Cicek D, Polat G, Akkus MN, Döven O, et al. Endothelin-1 and nitric oxide concentrations and their response to exercise in patients with slow coronary flow. Circ J. 2003;67:1022–8.
Pekdemir H, Polat G, Cin VG, Camsari A, Cicek D, Akkus MN, et al. Elevated plasma endothelin-1 levels in coronary sinus during rapid right atrial pacing in patients with slow coronary flow. Int J Cardiol. 2004;97:35–41.
Afsin A, Kaya H, Suner A, Uzel KE, Bursa N, Hosoglu Y, et al. Plasma atherogenic indices are independent predictors of slow coronary flow. BMC Cardiovasc Disord. 2021;21:608.
Zhu Q, Zhao C, Wang Y, Li X, Xue Y, Ma C. LncRNA NEAT1 promote inflammatory responses in coronary slow flow through regulating miR-148b-3p/ICAM-1 axis. J Inflamm Res. 2021;14:2445–63.
Tapar GG, Elcik D, Dogan A, Altunel E, Inanc MT, Alcali B, et al. An investigation of the relationship between arterial aortic stiffness and coronary slow flow that was detected during coronary angiography. Echocardiography. 2020;37:528–35.
Zhang X, Ding J, Xia S. A preliminary study of MMP-9 and sCD40L in patients with coronary slow flow. Ann Palliat Med. 2021;10:657–63.
Yang Z, Yuan J, Cui J, Guan H, Qiao S. Association of the lymphocyte-to-monocyte ratio, mean diameter of coronary arteries, and uric acid level with coronary slow flow in isolated coronary artery ectasia. BMC Cardiovasc Disord. 2021;21:156.
Gazi E, Barutcu A, Altun B, Temiz A, Bekler A, Urfali M, et al. Intercellular adhesion molecule-1 K469E and angiotensinogen T207M polymorphisms in coronary slow flow. Med Princ Pract. 2014;23:346–50.
Demirci E, Çelik O, Kalçık M, Bekar L, Yetim M, Doğan T. Evaluation of homocystein and asymmetric dimethyl arginine levels in patients with coronary slow flow phenomenon. Interv Med Appl Sci. 2019;11:89–94.
Weferling M, Vietheer J, Keller T, Fischer-Rasokat U, Hamm CW, Liebetrau C. Association between primary coronary slow-flow phenomenon and epicardial fat tissue. J Invasive Cardiol. 2021;33:E59-64.
Javadi H, Sotudeh S, Javadi A, Rezaee M, Hajikarimi M. Echocardiographic evaluation of left and right ventricular function in patients with coronary slow flow syndrome: a comparative study. Curr Probl Cardiol. 2022;47: 100925.
Acknowledgements
Not applicable.
Funding
This study was supported by the Doctoral Scientific Research Start-Up Foundation of Liaoning Province (No. 2022010609-JH3/101), and the Natural Science Foundation of Liaoning Province (No. 2018225024 and No. 2020JH2/10300119). The funders play an important role in study design, data analysis, and preparation of the manuscript.
Author information
Authors and Affiliations
Contributions
All authors have made a substantial intellectual contribution to this study. JT, GGB, LBZ, and BQY designed the study together. BQY contributed to administrative support. JT and GGB contributed to data collection. JT and LBZ contributed to data analysis. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
This study was a secondary analysis of publicly available data. Therefore, ethical review and consent were not required.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Tong, J., Bei, GG., Zhang, LB. et al. Coronary slow flow research: a bibliometric analysis. Eur J Med Res 28, 398 (2023). https://doi.org/10.1186/s40001-023-01326-w
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s40001-023-01326-w